ArticleCancer medicine2020

Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.

Adam R Wolfe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.